RESUMEN
The genome of Alphaviruses can be modified to produce self-replicating RNAs and virus-like particles, which are useful virological tools. In this work, we generated three plasmids for the transfection of mammalian cells: an infectious clone of Chikungunya virus (CHIKV), one that codes for the structural proteins (helper plasmid), and another one that codes nonstructural proteins (replicon plasmid). All of these plasmids contain a reporter gene (mKate2). The reporter gene in the replicon RNA and the infectious clone are synthesized from subgenomic RNA. Co-transfection with the helper and replicon plasmids has biotechnological/biomedical applications because they allow for the delivery of self-replicating RNA for the transient expression of one or more genes to the target cells.
Asunto(s)
Virus Chikungunya , Animales , Virus Chikungunya/genética , Virus Chikungunya/metabolismo , Replicación Viral/genética , Transfección , Plásmidos/genética , ARN/metabolismo , Replicón , Vectores Genéticos/genética , MamíferosRESUMEN
Las enfermedades cardiovasculares son una de las principales causas de mortalidad siendo los trastornos del ritmo cardiaco una de las patologías cardiacas más frecuentes. La cardioversión eléctrica es una técnica a través de la cual se realiza una transferencia de electrones al miocardio con la finalidad de interrumpir arritmias con mecanismos de reentrada permitiendo al nodo sinusal retomar el control de la frecuencia cardiaca. La correcta selección de los casos susceptibles de cardioversión eléctrica y experiencia en cardioversión aumenta la tasa de éxito y disminuye el número de choques fallidos. En el CCR- ASCARDIO, la Unidad de Electrocardiología cuenta con experiencia en el estudio y tratamiento de arritmias. En este artículo se presenta la elaboración de un programa de adiestramiento en la técnica de cardioversión eléctrica siendo esta terapia una herramienta imprescindible para la práctica clínica del cardiólogo, facilitando la prevención de complicaciones derivadas de los trastornos del ritmo cardiaco(AU)
Cardiovascular diseases are one of the main causes of mortality worldwide being heart rhythm disorders one of the most frequent cardiac pathologies. Electrical cardioversion is a technique that allows the transfer of electrons to the myocardium in order to interrupt arrhythmias with reentry mechanisms allowing the sinus node to take control of heart rate. The appropriate selection of cases susceptible to electrical cardioversion as well as experience on this technique increases the success rate and decreases the number of failed attempts. The Electrocardiology unit of the CCR-ASCARDIO has experience in the study and treatment of arrhythmias. In this article we present the development of a training program on electrical cardioversion, essential tool for cardiologists, with the aim to increase the correct use of this technique in order to prevent complications due to heart rhythm disorders(AU)
Asunto(s)
Humanos , Masculino , Femenino , Cardioversión Eléctrica , Enfermedades Cardiovasculares/complicaciones , Enfermedades Cardiovasculares/mortalidad , Cursos de Capacitación , Arritmias Cardíacas/patología , Fibrilación Atrial , Desarrollo de PersonalRESUMEN
Therapeutic approaches that promote both neuroprotection and neuroregeneration would be valuable for spinal cord (SC) injury therapies. Cyclosporin-A (CsA) is an immunosuppressant that, due to its mechanism of action, could both protect and regenerate the neural tissue after injury. Previous studies have already demonstrated that intraperitoneal administration of CsA at a dose of 2.5 mg/kg/12 h during the first 2 days after SC contusion, followed by 5 mg/kg/12 h orally, diminishes tissue damage and improves motor recovery. In order to evaluate the effect of this CsA dosing regimen on axonal growth, we assessed motor recovery, presence of axons establishing functional connections and expression of GAP-43 in rats subjected to a complete SC transection. The Basso-Beattie-Bresnahan rating scale did not show difference in motor recovery of CsA or vehicle-treated rats. Moreover, somato-sensorial evoked potentials demonstrated no functional connections in the SC of these animals. Nevertheless, histological studies showed that: i) a significant number of CsA-treated rats presented growing axons, although they deviated perpendicularly at the edge of the stumps, surrounding them, ii) the expression of GAP-43 in animals treated with CsA was higher than that observed in the control group. Finally, anterograde tracing of the corticospinal tract of rats subjected to an incomplete SC transection showed no axonal fibers reaching the caudal stump. In summary, CsA administered at the dosing-regimen that promotes neuroprotection in SC contused rats induces both GAP-43 expression and axonal growth; however, it failed to generate functional connections in SC transected animals.